We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
+27.59%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$592M
AUM Growth
+$78.5M
Cap. Flow
+$48.3M
Cap. Flow %
8.16%
Top 10 Hldgs %
62.58%
Holding
88
New
16
Increased
4
Reduced
1
Closed
7

Top Buys

1
FNCH
Finch Therapeutics Group, Inc. Common Stock
FNCH
+$13.8M
2
ISLE
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
+$9.66M
3
FLNA
Filana Therapeutics
FLNA
+$8.48M
4
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$5.53M
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$4.6M

Top Sells

1
TGTX icon
TG Therapeutics
TGTX
+$3.9M
2
IDN icon
Intellicheck
IDN
+$2.99M
3
EOSEW
Eos Energy Enterprises Warrant
EOSEW
+$2.08M
4
HCARU
Healthcare Services Acquisition Corporation Unit
HCARU
+$1.53M
5
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
+$1.13M

Sector Composition

1 Healthcare 23.53%
2 Industrials 13.57%
3 Consumer Discretionary 12.6%
4 Materials 9.11%
5 Financials 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELC icon
51
Celcuity
CELC
$4.36B
$717K 0.12%
+50,000
New +$711K
ARKOW
52
DELISTED
ARKO Corp Warrant
ARKOW
$683K 0.12%
333,333
– –
LBTYA icon
53
Liberty Global Class A
LBTYA
$3.53B
$590K 0.1%
22,989
– –
BATRK icon
54
Atlanta Braves Holdings Series B
BATRK
$3.33B
$576K 0.1%
20,717
– –
RTX icon
55
RTX Corp
RTX
$263B
$464K 0.08%
6,000
– –
FGNA.WS
56
DELISTED
FG New America Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A c
FGNA.WS
$385K 0.07%
250,000
– –
LHX icon
57
L3Harris
LHX
$53B
$324K 0.05%
1,600
– –
XFOR icon
58
X4 Pharmaceuticals
XFOR
$358M
$308K 0.05%
1,191
– –
BATRA icon
59
Atlanta Braves Holdings Series A
BATRA
$3.65B
$295K 0.05%
10,356
– –
CARR icon
60
Carrier Global
CARR
$57.4B
$253K 0.04%
6,000
– –
ISLEW
61
DELISTED
Isleworth Healthcare Acquisition Corporation Warrant
ISLEW
$233K 0.04%
+500,000
New +$239K
LILAK icon
62
Liberty Latin America Class C
LILAK
$1.49B
$214K 0.04%
18,174
– –
LGF.B
63
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$212K 0.04%
16,413
– –
OTIS icon
64
Otis Worldwide
OTIS
$28B
$205K 0.03%
3,000
– –
PHYS icon
65
Sprott Physical Gold
PHYS
$14.4B
$168K 0.03%
12,540
– –
ROCRU
66
DELISTED
Roth CH Acquisition III Co. Unit
ROCRU
$150K 0.03%
+15,000
New +$150K
CZOO
67
DELISTED
Cazoo Group Ltd
CZOO
$103K 0.02%
5
– –
BNY
68
Bank of New York Mellon
BNY
$108B
$95K 0.02%
2,000
– –
TER icon
69
Teradyne
TER
$50.8B
$73K 0.01%
600
– –
CDNS icon
70
Cadence Design Systems
CDNS
$91.1B
$72K 0.01%
525
– –
XLNX
71
DELISTED
Xilinx Inc
XLNX
$66K 0.01%
530
– –
MO icon
72
Altria Group
MO
$123B
$61K 0.01%
1,200
– –
LITE icon
73
Lumentum
LITE
$56.8B
$60K 0.01%
660
– –
XOM icon
74
ExxonMobil
XOM
$614B
$60K 0.01%
1,075
– –
ABBV icon
75
AbbVie
ABBV
$454B
$56K 0.01%
515
– –
1 2
3
4

Similar funds

BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $578M AUM 16.23% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
GCM
Gibraltar Capital Management Tulsa, Oklahoma $581M AUM 18.65% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $581M AUM 17.6% 1-Year Est. Return

Bleichroeder LP's Q1 2021 Portfolio in Review

As of Q1 2021, Bleichroeder LP held 88 positions worth $592M, up 15% from $514M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Bleichroeder LP deployed $48.3M of net new capital in Q1 2021, opening 16 new positions and adding to 4 existing holdings. Its largest new stake was Finch Therapeutics Group, Inc. Common Stock: 27,014 shares worth $13.1M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Intellicheck, an estimated $2.99M trimmed.

  • Bleichroeder LP's largest Q1 2021 buy was Finch Therapeutics Group, Inc. Common Stock: 27,014 shares worth $13.1M.
  • Bleichroeder LP added most to Filana Therapeutics in Q1 2021, an estimated $8.48M increase.
  • Bleichroeder LP's biggest Q1 2021 reduction was Intellicheck, cutting an estimated $2.99M.
  • Bleichroeder LP fully exited TG Therapeutics in Q1 2021, selling an estimated $3.9M.
  • Bleichroeder LP's ten largest holdings make up 63% of its $592M portfolio in Q1 2021.
  • Bleichroeder LP opened 16 new positions and closed 7 in Q1 2021.
  • Bleichroeder LP's portfolio value rose 15% quarter-over-quarter to $592M.

Based on Bleichroeder LP's 13F filing for Q1 2021, filed 17 May 2021.